An organelle-specific protein landscape identifies novel diseases and molecular mechanisms

Karsten Boldt, Jeroen van Reeuwijk(Radboud University Nijmegen), Qianhao Lu(Heidelberg University), Konstantinos Koutroumpas(Centre National de la Recherche Scientifique), Thanh-Minh T. Nguyen(Radboud University Nijmegen), Yves Texier(Center for Integrated Protein Science Munich), Sylvia E. C. van Beersum(Radboud University Nijmegen), Nicola Horn, Jason R. Willer(Duke University), Dorus A. Mans(Radboud University Nijmegen), Gerard W. Dougherty(University Hospital Münster), Ideke J.C. Lamers(Radboud University Nijmegen), Karlien L. M. Coene(Radboud University Nijmegen), Heleen H. Arts(Radboud University Nijmegen), Matthew J. Betts(Heidelberg University), Tina Beyer, Emine Bolat(Radboud University Nijmegen), Christian Johannes Gloeckner(German Center for Neurodegenerative Diseases), Khatera Haidari(University Medical Center Utrecht), Lisette Hetterschijt(Radboud University Nijmegen), Daniela Iaconis(Telethon Institute Of Genetics And Medicine), Dagan Jenkins(University College London), Franziska Klose, Barbara Knapp(Johannes Gutenberg University Mainz), Brooke Latour(Radboud University Nijmegen), Stef J.F. Letteboer(Radboud University Nijmegen), Carlo Marcelis(Radboud University Nijmegen), Dragana Mitic, Manuela Morleo(Federico II University Hospital), Machteld M. Oud(Radboud University Nijmegen), Moniek Riemersma(Radboud University Nijmegen), Susan Rix(University College London), Paulien A. Terhal(University Medical Center Utrecht), Grischa Toedt(European Molecular Biology Laboratory), Teunis J. P. van Dam(Radboud University Nijmegen), Erik de Vrieze(Radboud University Nijmegen), Yasmin Wissinger, Ka Man Wu(Radboud University Nijmegen), Gordana Apic, Philip L. Beales(University College London), Oliver E. Blacque(University College Dublin), Toby J. Gibson(European Molecular Biology Laboratory), Martijn A. Huynen(Radboud University Nijmegen), Nicholas Katsanis(Duke University), Hannie Kremer(Radboud University Nijmegen), Heymut Omran(University Hospital Münster), Erwin van Wijk(Radboud University Nijmegen), Uwe Wolfrum(Johannes Gutenberg University Mainz), François Képès(Centre National de la Recherche Scientifique), Erica E. Davis(Duke University), Brunella Franco(Federico II University Hospital), Rachel H. Giles(University Medical Center Utrecht), Marius Ueffing, Robert B. Russell(Heidelberg University), Ronald Roepman(Radboud University Nijmegen), UK10K Rare Diseases Group(Wellcome Sanger Institute), Saeed Al-Turki(King Abdulaziz Medical City), Carl E. Anderson(University College London), Dinu Antony(Wellcome Sanger Institute), Inês Barroso(Centre for Human Genetics), Jamie Bentham(Centre for Human Genetics), Shoumo Bhattacharya(Wellcome Sanger Institute), Keren Carss(University of Cambridge), Krishna Chatterjee(Great Ormond Street Hospital), Sebahattin Çirak(Centre for Human Genetics), Catherine Cosgrove(Wellcome Sanger Institute), Petr Danecek(Wellcome Sanger Institute), Richard Durbin(Western General Hospital), David Fitzpatrick(Wellcome Sanger Institute), Jamie Floyd(Great Ormond Street Hospital), A. Reghan Foley(Wellcome Sanger Institute), Chris Franklin(University College London), Marta Futema(University College London), Steve E. Humphries(Wellcome Sanger Institute), Matt Hurles(Wellcome Sanger Institute), Christopher Joyce(Wellcome Sanger Institute), Shane McCarthy(University College London), Hannah M. Mitchison(Wellcome Sanger Institute), Dawn Muddyman(Great Ormond Street Hospital), Francesco Muntoni(University of Cambridge), Stephen O’Rahilly(University College London), Alexandros Onoufriadis(Wellcome Sanger Institute), Felicity Payne(University College London), Vincent Plagnol(University of Cambridge), Lucy Raymond(University of Cambridge), David B. Savage(University College London), Peter Scambler(University College London), Miriam Schmidts(University of Cambridge), Nadia Schoenmakers(University of Cambridge), Robert K. Semple(Wellcome Sanger Institute), Eva Serra(Wellcome Sanger Institute), Jim Stalker(Wellcome Sanger Institute), Margriet van Kogelenberg(Wellcome Sanger Institute), Parthiban Vijayarangakannan(Wellcome Sanger Institute), Klaudia Walter(University College London), Ros Whittall(Western General Hospital), Kathy Williamson
Nature Communications
May 13, 2016
Cited by 259Open Access
Full Text

Abstract

Cellular organelles provide opportunities to relate biological mechanisms to disease. Here we use affinity proteomics, genetics and cell biology to interrogate cilia: poorly understood organelles, where defects cause genetic diseases. Two hundred and seventeen tagged human ciliary proteins create a final landscape of 1,319 proteins, 4,905 interactions and 52 complexes. Reverse tagging, repetition of purifications and statistical analyses, produce a high-resolution network that reveals organelle-specific interactions and complexes not apparent in larger studies, and links vesicle transport, the cytoskeleton, signalling and ubiquitination to ciliary signalling and proteostasis. We observe sub-complexes in exocyst and intraflagellar transport complexes, which we validate biochemically, and by probing structurally predicted, disruptive, genetic variants from ciliary disease patients. The landscape suggests other genetic diseases could be ciliary including 3M syndrome. We show that 3M genes are involved in ciliogenesis, and that patient fibroblasts lack cilia. Overall, this organelle-specific targeting strategy shows considerable promise for Systems Medicine.


Related Papers

No related papers found

Powered by citation graph analysis